Medicines update

Let's take a look at the monthly update of new and altered medicine listings from MIMS Australia  New Products Faricimab (Vabysmo) is a humanised bispecific immunoglobulin G1 (IgG1) antibody that acts through inhibition of two distinct pathways by neutralisation of both Ang‑2 and vascular endothelial growth factor A (VEGF‑A). Ang‑2 causes vascular instability by promoting